These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 6114797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electrophysiological effects of melperone in the dog heart in situ - a new antiarrhythmic drug.
    Refsum H, Amlie JP, Platou ES, Owren T, Landmark K.
    Cardiovasc Res; 1981 Mar; 15(3):131-6. PubMed ID: 6114796
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels and cardiac electrophysiological effects of melperone in the dog.
    Platou ES, Refsum H, Amlie JP, Landmark K.
    Eur J Pharmacol; 1982 Aug 13; 82(1-2):1-7. PubMed ID: 7128676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The mode of antiarrhythmic action of melperone.
    Platou ES, Refsum H, Myhre ES, Amlie JP, Landmark K.
    Acta Pharmacol Toxicol (Copenh); 1982 Feb 13; 50(2):108-12. PubMed ID: 6122332
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential actions on rabbit nodal, atrial, Purkinje cell and ventricular potentials of melperone, a bradycardic agent delaying repolarization: effects of hypoxia.
    Millar JS, Vaughan Williams EM.
    Br J Pharmacol; 1982 Jan 13; 75(1):109-21. PubMed ID: 7074278
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M, Nakaya H, Hattori Y, Izumi T, Nishimura T, Sakai K, Abiko Y.
    Nihon Yakurigaku Zasshi; 1980 Oct 13; 76(7):621-32. PubMed ID: 6111522
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Electrophysiological effects of alpha-adrenergic stimulation.
    Talajic M, Villemaire C, Nattel S.
    Pacing Clin Electrophysiol; 1990 May 13; 13(5):578-82. PubMed ID: 1693193
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea.
    Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M.
    Hypertension; 2012 Jul 13; 60(1):172-8. PubMed ID: 22585944
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiological effects of thoracic epidural analgesia in the dog heart in situ.
    Hotvedt R, Platou ES, Refsum H.
    Cardiovasc Res; 1983 May 13; 17(5):259-66. PubMed ID: 6883401
    [Abstract] [Full Text] [Related]

  • 19. Haemodynamic and metabolic effects of the antiarrhythmic drug melperone during acute left ventricular failure in dogs.
    Smiseth OA, Platou ES, Refsum H, Mjøs OD.
    Cardiovasc Res; 1981 Dec 13; 15(12):724-30. PubMed ID: 7326689
    [Abstract] [Full Text] [Related]

  • 20. Does beta-blockade directly reduce myocardial oxygen consumption?
    Thomas M, Gabe IT, Kimber H, Mills CJ, Sweeting TJ.
    Cardiovasc Res; 1981 May 13; 15(5):254-61. PubMed ID: 6117372
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.